Magne-B6 gets a makeover: new tablet tested against old liquid
NCT ID NCT06386211
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times
Summary
This study tested whether a new tablet form of Magne-B6 releases magnesium and vitamin B6 into the body as well as the current liquid version. Twenty-four healthy adults took both forms in random order and had their blood and urine levels measured. The goal was to see if the tablet could be a good alternative to the liquid.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Magne-B6 (magnesium and pyridoxine)
- What this could lead to
- If the new tablet works as well as the solution, it could offer a more convenient way to take Magne-B6.
- What could go wrong
- This is a small, early-stage study in healthy volunteers, so results may not apply to people with medical conditions. The new tablet might not absorb as well as the solution.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Erciyes Universitesi Hakan Cetinsaya Iyi Klinik Uygulama ve Araştırma Merkezi Erciyes Universitesi Kampusu
Kayseri, 38039, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug pass its first safety hurdle?
- Can a new drug play nice with common medicines? a trial investigates
- Could a new pill quiet chronic pain? early trial puts it to the test
- Brain waves under pressure: can light uncover the signature of mental work?
- Can acting as patients teach nurses to truly listen?
- Who decides for you? survey asks incarcerated older adults